GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CNBX Pharmaceuticals Inc (OTCPK:CNBX) » Definitions » Net Margin %

CNBX Pharmaceuticals (CNBX Pharmaceuticals) Net Margin % : -792.68% (As of Feb. 2024)


View and export this data going back to 2007. Start your Free Trial

What is CNBX Pharmaceuticals Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. CNBX Pharmaceuticals's Net Income for the three months ended in Feb. 2024 was $-0.33 Mil. CNBX Pharmaceuticals's Revenue for the three months ended in Feb. 2024 was $0.04 Mil. Therefore, CNBX Pharmaceuticals's net margin for the quarter that ended in Feb. 2024 was -792.68%.

The historical rank and industry rank for CNBX Pharmaceuticals's Net Margin % or its related term are showing as below:

CNBX' s Net Margin % Range Over the Past 10 Years
Min: -106671.43   Med: -14640   Max: 11330
Current: -228.33


CNBX's Net Margin % is ranked worse than
54.5% of 1033 companies
in the Biotechnology industry
Industry Median: -162.58 vs CNBX: -228.33

CNBX Pharmaceuticals Net Margin % Historical Data

The historical data trend for CNBX Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CNBX Pharmaceuticals Net Margin % Chart

CNBX Pharmaceuticals Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,330.00 -106,671.43 - -14,640.00 -904.88

CNBX Pharmaceuticals Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -50.00 -574.00 -201.12 -792.68

Competitive Comparison of CNBX Pharmaceuticals's Net Margin %

For the Biotechnology subindustry, CNBX Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CNBX Pharmaceuticals's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CNBX Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where CNBX Pharmaceuticals's Net Margin % falls into.



CNBX Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

CNBX Pharmaceuticals's Net Margin for the fiscal year that ended in Aug. 2023 is calculated as

Net Margin=Net Income (A: Aug. 2023 )/Revenue (A: Aug. 2023 )
=-3.71/0.41
=-904.88 %

CNBX Pharmaceuticals's Net Margin for the quarter that ended in Feb. 2024 is calculated as

Net Margin=Net Income (Q: Feb. 2024 )/Revenue (Q: Feb. 2024 )
=-0.325/0.041
=-792.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CNBX Pharmaceuticals  (OTCPK:CNBX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


CNBX Pharmaceuticals Net Margin % Related Terms

Thank you for viewing the detailed overview of CNBX Pharmaceuticals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CNBX Pharmaceuticals (CNBX Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814
CNBX Pharmaceuticals Inc is a biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. The firm's main product is the RCC-33, an oral capsule for the treatment of colorectal cancer. The company tools include delivery systems, personalized medicine diagnostics, and therapies based on Cannabinoid compounds.
Executives
Cannabics Inc. 10 percent owner 108 WEST 13TH ST., WILMINGTON DE 19801
Thomas E Mills director, officer: President, CEO, CFO
North American Mining Corp 10 percent owner 6767 WEST TROPICANA AVENUE, SUITE 229, LAS VEGAS NV 89103
Lou Hilford director, officer: Vice-President, Secretary